BECN2 Research Linked Receptor Recycling to Cannabinoid Tolerance in Mice

Receptor loss and receptor recycling can affect continued cannabinoid responses. Research on BECN2 linked a cellular trafficking mechanism with tolerance in mice, but it did not establish a consumer strategy for preventing cannabis tolerance.

A pathway connecting cells and behavior

The supplied abstract describes BECN2 as participating in regulation of CB1 receptor recycling and resensitization after prolonged agonist exposure. The investigators combined molecular work with a mouse genetic model and repeated-cannabinoid behavioral testing.

The intervention concerned a specific mechanism

Becn2 deletion preserved receptor activity and reduced analgesic tolerance in the reported model. Selected autophagy-inducing interventions also affected the interaction between BECN2 and GPRASP1, with corresponding effects on receptor levels, signaling and mouse tolerance.

Autophagy is not one universal treatment

A biological pathway can have different consequences depending on the cell, timing and intervention. Evidence that particular experimental manipulations altered receptor handling does not show that any supplement, diet or activity marketed as promoting autophagy reproduces the effect.

The result also concerns tolerance to selected antinociceptive effects rather than a comprehensive measurement of intoxication, dependence or safety. Mouse brain receptor findings cannot identify whether an individual driver was impaired. The study supports a mechanistic research direction while leaving human effectiveness, adverse effects and appropriate clinical use unanswered. Descriptions should name the actual manipulation instead of converting the pathway into an untested wellness recommendation.

Related: interpreting cannabis tolerance claims.

Research cited

Kuramoto K; Wang N; Fan Y; Zhang W; Schoenen FJ; Frankowski KJ; Marugan J; Zhou Y; Huang S; He C. Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids. Autophagy (2016). doi:10.1080/15548627.2016.1187367. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us